Liposomal Irinotecan (nal-IRI)

DRUG2 trials

Sponsors

Devalingam Mahalingam, Guangdong Provincial People's Hospital

Conditions

KRAS P.G12CMetastatic Pancreatic CancerPancreatic CancerRectal Cancer PatientsUnresectable Pancreatic Cancer

Phase 1

Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer

WithdrawnNCT05251038

Devalingam MahalingamKRAS P.G12C, Metastatic Pancreatic Cancer, Pancreatic Cancer +1

Start: 2022-09-13End: 2023-01-31Updated: 2023-05-11

Phase 2

Short-Course Radiotherapy, Nal-IRI, Capecitabine, and Camrelizumab for Locally Advanced MSS Rectal Cancer

Not yet recruitingNCT07521605

Guangdong Provincial People's HospitalRectal Cancer Patients

Start: 2026-05-20End: 2034-12-31Target: 44Updated: 2026-04-13